Abstract
IL-2-loaded liposomes modified with sorafenib derivative exert a synergistic anti-melanoma effect via improving tumor immune microenvironment and enhancing antiangiogenic activity
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have